PKB Signaling and Atrogene Expression in Skeletal Muscle of Aged Mice

Overview

Journal J Appl Physiol (1985)

Publisher American Physiological Society

Date 2011 May 10

PMID 21551011

Citations 34

Authors

Megan Gaugler

Alicia Brown

Erin Merrell

Maria DiSanto-Rose

John A Rathmacher

Thomas H Reynolds 4th

Affiliations

Soon will be listed here.

Abstract

The purpose of this study was to determine if PKB signaling is decreased and contractile protein degradation is increased in extensor digitorum longus (EDL) and soleus (SOL) muscles from middle-aged (MA) and aged (AG) mice. We also examined the effect of age on atrogene expression in quadriceps muscle. PKB activity, as assessed by Thr(308) and Ser(473) phosphorylation, was significantly higher in EDL and SOL muscles from AG than MA mice. The age-related increase in PKB activity appears to be due to an increase in expression of the kinase, as PKB-α and PKB-β levels were significantly higher in EDL and SOL muscles from AG than MA mice. The phosphorylation of forkhead box 3a (FOXO3a) on Thr(32), a PKB target, was significantly higher in EDL muscles from AG than MA mice. The rate of contractile protein degradation was similar in EDL and SOL muscles from AG and MA mice. Atrogin-1 and muscle-specific RING finger protein 1 (MuRF-1) mRNA levels did not change in muscles from AG compared with MA mice, indicating that ubiquitin-proteasome proteolysis does not contribute to sarcopenia. A significant decrease in Bcl-2 and 19-kDa interacting protein 3 (Bnip3) and GABA receptor-associated protein 1 (Gabarap1) mRNA was observed in muscles from AG compared with MA mice, which may contribute to age-related contractile dysfunction. In conclusion, the mechanisms responsible for sarcopenia are distinct from experimental models of atrophy and do not involve atrogin-1 and MuRF-1 or enhanced proteolysis. Finally, a decline in autophagy-related gene expression may provide a novel mechanism for impaired contractile function and muscle metabolism with advancing age.

Citing Articles

Sarcopenic obesity is attenuated by E-syt1 inhibition via improving skeletal muscle mitochondrial function.

Song C, Zheng W, Liu G, Xu Y, Deng Z, Xiu Y Redox Biol. 2024; 79():103467.

PMID: 39675068 PMC: 11699297. DOI: 10.1016/j.redox.2024.103467.

The Oldest of Old Male C57B/6J Mice Are Protected from Sarcopenic Obesity: The Possible Role of Skeletal Muscle Protein Kinase B Expression.

Reynolds 4th T, Mills N, Hoyte D, Ehnstrom K, Arata A Int J Mol Sci. 2024; 25(19).

PMID: 39408607 PMC: 11476861. DOI: 10.3390/ijms251910278.

Melatonin and Exercise Counteract Sarcopenic Obesity through Preservation of Satellite Cell Function.

Mankhong S, Kim S, Moon S, Lee J, Cho E, Kwak H Int J Mol Sci. 2023; 24(7).

PMID: 37047070 PMC: 10094434. DOI: 10.3390/ijms24076097.

The Role of Mitophagy in Skeletal Muscle Damage and Regeneration.

Chatzinikita E, Maridaki M, Palikaras K, Koutsilieris M, Philippou A Cells. 2023; 12(5).

PMID: 36899852 PMC: 10000750. DOI: 10.3390/cells12050716.

Mammalian Target of Rapamycin (mTOR) Signaling at the Crossroad of Muscle Fiber Fate in Sarcopenia.

Sirago G, Picca A, Calvani R, Coelho-Junior H, Marzetti E Int J Mol Sci. 2022; 23(22).

PMID: 36430301 PMC: 9696247. DOI: 10.3390/ijms232213823.

References

Raue U, Slivka D, Jemiolo B, Hollon C, Trappe S . Proteolytic gene expression differs at rest and after resistance exercise between young and old women. J Gerontol A Biol Sci Med Sci. 2008; 62(12):1407-12. DOI: 10.1093/gerona/62.12.1407. View

Price S, Bailey J, Wang X, Jurkovitz C, England B, Ding X . Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J Clin Invest. 1996; 98(8):1703-8. PMC: 507607. DOI: 10.1172/JCI118968. View

Masiero E, Agatea L, Mammucari C, Blaauw B, Loro E, Komatsu M . Autophagy is required to maintain muscle mass. Cell Metab. 2009; 10(6):507-15. DOI: 10.1016/j.cmet.2009.10.008. View

Wohlgemuth S, Seo A, Marzetti E, Lees H, Leeuwenburgh C . Skeletal muscle autophagy and apoptosis during aging: effects of calorie restriction and life-long exercise. Exp Gerontol. 2009; 45(2):138-48. PMC: 2829942. DOI: 10.1016/j.exger.2009.11.002. View

Timmerman K, Volpi E . Amino acid metabolism and regulatory effects in aging. Curr Opin Clin Nutr Metab Care. 2007; 11(1):45-9. PMC: 2804959. DOI: 10.1097/MCO.0b013e3282f2a592. View

Altun M, Besche H, Overkleeft H, Piccirillo R, Edelmann M, Kessler B . Muscle wasting in aged, sarcopenic rats is associated with enhanced activity of the ubiquitin proteasome pathway. J Biol Chem. 2010; 285(51):39597-608. PMC: 3000941. DOI: 10.1074/jbc.M110.129718. View

Balagopal P, Rooyackers O, Adey D, Ades P, Nair K . Effects of aging on in vivo synthesis of skeletal muscle myosin heavy-chain and sarcoplasmic protein in humans. Am J Physiol. 1997; 273(4):E790-800. DOI: 10.1152/ajpendo.1997.273.4.E790. View

Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A . Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 2004; 117(3):399-412. PMC: 3619734. DOI: 10.1016/s0092-8674(04)00400-3. View

Bodine S, Latres E, Baumhueter S, Lai V, Nunez L, Clarke B . Identification of ubiquitin ligases required for skeletal muscle atrophy. Science. 2001; 294(5547):1704-8. DOI: 10.1126/science.1065874. View

10.

Alessi D, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P . Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996; 15(23):6541-51. PMC: 452479. View

11.

Sarbassov D, Guertin D, Ali S, Sabatini D . Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005; 307(5712):1098-101. DOI: 10.1126/science.1106148. View

12.

Rasmussen B, Fujita S, Wolfe R, Mittendorfer B, Roy M, Rowe V . Insulin resistance of muscle protein metabolism in aging. FASEB J. 2006; 20(6):768-9. PMC: 2804965. DOI: 10.1096/fj.05-4607fje. View

13.

Faridi J, Fawcett J, Wang L, Roth R . Akt promotes increased mammalian cell size by stimulating protein synthesis and inhibiting protein degradation. Am J Physiol Endocrinol Metab. 2003; 285(5):E964-72. DOI: 10.1152/ajpendo.00239.2003. View

14.

Furuno K, Goodman M, GOLDBERG A . Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy. J Biol Chem. 1990; 265(15):8550-7. View

15.

Lecker S, Jagoe R, Gilbert A, Gomes M, Baracos V, Bailey J . Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 2004; 18(1):39-51. DOI: 10.1096/fj.03-0610com. View

16.

Janssen I, Shepard D, Katzmarzyk P, Roubenoff R . The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2003; 52(1):80-5. DOI: 10.1111/j.1532-5415.2004.52014.x. View

17.

Newby F, Price S . Determinants of protein turnover in health and disease. Miner Electrolyte Metab. 1997; 24(1):6-12. DOI: 10.1159/000057344. View

18.

Evans W, Paolisso G, Abbatecola A, Corsonello A, Bustacchini S, Strollo F . Frailty and muscle metabolism dysregulation in the elderly. Biogerontology. 2010; 11(5):527-36. DOI: 10.1007/s10522-010-9297-0. View

19.

DeFronzo R . Glucose intolerance and aging. Diabetes Care. 1981; 4(4):493-501. DOI: 10.2337/diacare.4.4.493. View

20.

Rathmacher J, Link G, Flakoll P, Nissen S . Gas chromatographic/mass spectrometric analysis of stable isotopes of 3-methylhistidine in biological fluids: application to plasma kinetics in vivo. Biol Mass Spectrom. 1992; 21(11):560-6. DOI: 10.1002/bms.1200211107. View